BiotechTV - News
BiotechTV - News
BiotechTV
Episodes
About
Reviews
Promote
Monte Rosa Therapeutics announced data for MRT-8102, its NEK7-directed molecular glue degrader, showing positive impact on biomarkers linked to atherosclerotic cardiovascular disease
20 minutes Posted Oct 2, 2026 at 1:00 pm.
0:00
20:49
Download MP3
Show notes

CEO Markus Warmuth walks us through the data and provides a broader update on the pipeline progress at Monte Rosa and for the field of degraders and molecular glues more broadly.

This podcast uses Anchor (from Spotify) for stats, tracking, and dynamic audio. Learn more on this podcast's About tab.
← See all 489 episodes of BiotechTV - News
Podbay © 2026 Fancy Soups
About